Clinical Approach to Rash

Pediatric Comprehensive Framework

1
Symptom Overview
Overview
2
Pathophysiology
Mechanism
3
History Taking
History
4
Physical Examination
Examination
5
Differential Diagnosis
Differential
6
Investigations
Workup
7
Clinical Decision-Making
Algorithm
8
Pearls and Pitfalls
Summary

1. Symptom Overview

Understanding the clinical significance and classification of pediatric rash

Rash is one of the most common presenting complaints in pediatric practice, accounting for approximately 12-15% of all pediatric outpatient visits and up to 30% of dermatology referrals in children. Cutaneous eruptions in children present unique diagnostic challenges due to the wide spectrum of potential etiologies ranging from benign self-limiting viral exanthems to life-threatening conditions such as meningococcemia or Kawasaki disease. The ability to rapidly distinguish between these entities is a critical skill for any clinician caring for children.

Definition

A rash (exanthem) is any visible change in the color, texture, or appearance of the skin. In pediatrics, rashes represent cutaneous manifestations of diverse underlying processes including infections, inflammatory conditions, allergic reactions, autoimmune diseases, and systemic illnesses. The skin serves as a window to both local dermatological pathology and systemic disease states.

Key Epidemiology

Rash accounts for 12-15% of pediatric outpatient visits
Viral exanthems represent the most common cause (over 70% of acute rashes)
Atopic dermatitis affects 15-20% of children worldwide
Urticaria occurs in approximately 15-25% of children at some point
Peak incidence of viral exanthems occurs between 6 months and 3 years of age
Petechial rashes, while less common, require urgent evaluation in 100% of cases

Classification by Duration

Category	Duration	Common Causes	Clinical Significance
Acute	Less than 2 weeks	Viral exanthems, urticaria, drug eruptions, bacterial infections, allergic contact dermatitis	Most common presentation; priority is excluding serious bacterial infection and identifying life-threatening causes
Subacute	2 to 6 weeks	Pityriasis rosea, guttate psoriasis, persistent urticaria, scabies	Often represents evolution of acute process or emergence of chronic condition; reassess diagnosis if not improving
Chronic	Greater than 6 weeks	Atopic dermatitis, psoriasis, chronic urticaria, tinea infections, ichthyosis	Requires systematic approach to identify underlying etiology; significant quality of life impact; consider referral to dermatology

Classification by Morphology

The morphology of skin lesions provides crucial diagnostic information. Accurate identification of the primary lesion type is fundamental to generating an appropriate differential diagnosis.

Primary Lesions

Lesion Type	Description	Size Criteria	Examples in Pediatrics
Macule	Flat, non-palpable change in skin color	Less than 1 cm	Measles prodrome, café-au-lait spots, vitiligo
Patch	Flat, non-palpable change in skin color	Greater than 1 cm	Tinea versicolor, port-wine stain, mongolian spots
Papule	Elevated, palpable, solid lesion	Less than 1 cm	Molluscum contagiosum, insect bites, warts
Plaque	Elevated, palpable, flat-topped lesion	Greater than 1 cm	Psoriasis, atopic dermatitis, tinea corporis
Vesicle	Fluid-filled, elevated lesion with clear fluid	Less than 1 cm	Varicella, herpes simplex, hand-foot-mouth disease
Bulla	Fluid-filled, elevated lesion with clear fluid	Greater than 1 cm	Bullous impetigo, Stevens-Johnson syndrome, burns
Pustule	Elevated lesion containing purulent material	Any size	Folliculitis, acne, erythema toxicum neonatorum
Wheal (Hive)	Transient, edematous, pruritic papule or plaque	Variable	Urticaria, allergic reactions
Petechiae	Non-blanching, pinpoint hemorrhage into skin	Less than 2 mm	Meningococcemia, Henoch-Schönlein purpura, thrombocytopenia
Purpura	Non-blanching hemorrhage into skin	Greater than 2 mm	Meningococcemia, idiopathic thrombocytopenic purpura, vasculitis

Classification by Distribution Pattern

Centrally Distributed

Pattern: Trunk involvement with variable spread to extremities

Examples: Viral exanthems (roseola, measles), drug eruptions, pityriasis rosea, scarlet fever

Clinical Pearl: Most classic viral exanthems begin centrally and spread peripherally

Peripherally Distributed

Pattern: Acral (hands, feet) or extremity-predominant involvement

Examples: Hand-foot-mouth disease, Rocky Mountain spotted fever (evolves to centripetal), erythema multiforme

Clinical Pearl: Peripheral-to-central spread should raise concern for Rocky Mountain spotted fever

Dermatomal

Pattern: Following distribution of specific dermatomes

Examples: Herpes zoster (rare in immunocompetent children), segmental vitiligo

Clinical Pearl: Herpes zoster in young children should prompt evaluation for underlying immunodeficiency

Flexural

Pattern: Antecubital fossae, popliteal fossae, neck creases, axillae

Examples: Atopic dermatitis (older children), intertrigo, inverse psoriasis

Clinical Pearl: Flexural involvement in infants with atopic dermatitis is less common; extensors are more typically affected

Classification by Associated Features

Associated Feature	Pattern Description	Conditions to Consider
Fever with rash	Rash appearing during or after febrile illness	Viral exanthems, Kawasaki disease, scarlet fever, meningococcemia, drug reaction
Pruritus (itching)	Rash accompanied by significant scratching	Urticaria, atopic dermatitis, scabies, contact dermatitis, varicella
Mucosal involvement	Oral, conjunctival, or genital mucosa affected	Stevens-Johnson syndrome, Kawasaki disease, hand-foot-mouth disease, measles
Desquamation (peeling)	Skin peeling following initial rash	Kawasaki disease, scarlet fever, staphylococcal scalded skin syndrome, toxic shock syndrome
Lymphadenopathy	Enlarged lymph nodes accompanying rash	Infectious mononucleosis, Kawasaki disease, rubella, cat scratch disease
Joint involvement	Arthralgia or arthritis with rash	Henoch-Schönlein purpura, juvenile idiopathic arthritis, acute rheumatic fever, serum sickness

Age-Specific Considerations

Age Group	Common Rash Presentations	Key Considerations
Neonate (0-28 days)	Erythema toxicum neonatorum, neonatal acne, milia, seborrheic dermatitis, transient neonatal pustular melanosis	Distinguish benign neonatal rashes from herpes simplex virus infection, bacterial sepsis, and congenital infections (TORCH); any vesicular rash requires urgent evaluation
Infant (1-12 months)	Seborrheic dermatitis, atopic dermatitis (extensors), diaper dermatitis, roseola, viral exanthems	Atopic dermatitis often presents on cheeks and extensor surfaces; Kawasaki disease has peak incidence in this age group
Toddler (1-3 years)	Hand-foot-mouth disease, viral exanthems, impetigo, molluscum contagiosum, urticaria	High exposure to viral pathogens in daycare settings; impetigo often spreads rapidly in this age group
School-age (4-12 years)	Atopic dermatitis (flexural), tinea infections, warts, pityriasis rosea, Henoch-Schönlein purpura	Atopic dermatitis shifts to flexural distribution; peak incidence for Henoch-Schönlein purpura and pityriasis rosea
Adolescent (13-18 years)	Acne vulgaris, pityriasis rosea, tinea infections, drug eruptions, psoriasis	Consider sexually transmitted infections; drug eruptions more common due to increased medication use; acne has significant psychosocial impact

Key Concept: The “Big Four” Questions for Any Pediatric Rash

Is this child sick or well-appearing? — A well-appearing child with a rash is unlikely to have a serious bacterial infection
Does this rash blanch with pressure? — Non-blanching rashes (petechiae/purpura) require immediate investigation for meningococcemia and coagulopathy
Is there mucosal involvement? — Mucosal involvement suggests more serious conditions including Stevens-Johnson syndrome and Kawasaki disease
What is the morphology of the primary lesion? — Accurate identification of the primary lesion narrows the differential significantly

2. Pathophysiology and Mechanisms

Understanding the underlying mechanisms of pediatric rash

Understanding the pathophysiological mechanisms underlying different types of rashes is essential for accurate diagnosis and targeted treatment. Skin eruptions in children result from several distinct mechanisms: direct pathogen invasion, immune-mediated responses, vascular phenomena, and inflammatory cascades. By recognizing the mechanism, clinicians can anticipate the natural course, potential complications, and appropriate therapeutic interventions.

Overview of Skin Structure in Children

Pediatric skin differs from adult skin in several important ways that influence disease presentation. Infant skin has a thinner stratum corneum, higher water content, greater permeability, and a less mature immune system. These developmental factors explain why certain conditions present differently or more severely in young children and why topical medications may have enhanced absorption and potential toxicity.

Skin Layer	Pediatric Considerations	Clinical Relevance
Epidermis	Thinner stratum corneum in infants; incomplete barrier function until 2 years of age	Increased susceptibility to irritants, allergens, and infections; enhanced percutaneous absorption of topical medications
Dermis	Less collagen density; greater water content; immature dermal-epidermal junction in neonates	Increased risk of blistering in neonatal conditions; more pronounced edema with inflammatory processes
Subcutis	Proportion of brown fat varies with age; subcutaneous fat distribution differs	Subcutaneous fat necrosis specific to neonates; panniculitis may present differently than in adults
Skin appendages	Eccrine glands immature until 2-3 years; sebaceous glands activated by maternal hormones then quiescent until puberty	Limited sweating capacity in infants affecting thermoregulation; neonatal acne related to maternal androgens

Mechanisms of Rash Development

1. Infectious Mechanisms

Direct Pathogen Invasion

Mechanism: Organisms directly infect skin cells or structures, causing cellular damage and visible eruption

Examples:

Varicella-zoster virus — infects keratinocytes causing vesicle formation
Herpes simplex virus — neurotropic virus with skin manifestations
Staphylococcus aureus in impetigo — epidermal infection with bullae formation
Dermatophytes (tinea) — fungal invasion of stratum corneum

Toxin-Mediated Injury

Mechanism: Bacterial toxins cause skin damage distant from site of infection

Examples:

Scarlet fever — streptococcal pyrogenic exotoxins cause diffuse erythema
Staphylococcal scalded skin syndrome — exfoliative toxins A and B cleave desmoglein-1
Toxic shock syndrome — superantigens cause massive cytokine release

2. Immune-Mediated Mechanisms

Immune Mechanism	Hypersensitivity Type	Pathophysiology	Pediatric Examples
Immediate (IgE-mediated)	Type I	Antigen cross-links IgE on mast cells, causing immediate degranulation with histamine release; leads to vasodilation, edema, and pruritus within minutes	Urticaria, angioedema, anaphylaxis with skin involvement
Cytotoxic (antibody-mediated)	Type II	Antibodies bind to cell surface antigens, leading to complement activation or antibody-dependent cellular cytotoxicity	Pemphigus (rare in children), bullous pemphigoid, autoimmune blistering diseases
Immune complex	Type III	Antigen-antibody complexes deposit in vessel walls, activating complement and causing vasculitis with vessel wall inflammation and purpura	Henoch-Schönlein purpura (IgA vasculitis), serum sickness, urticarial vasculitis
Delayed (T cell-mediated)	Type IV	Sensitized T lymphocytes recognize antigen and release cytokines, recruiting inflammatory cells over 24-72 hours	Allergic contact dermatitis, tuberculin reaction, morbilliform drug eruptions, graft-versus-host disease

3. Vascular Mechanisms

Vasodilation

Mechanism: Blood vessel dilation causes erythema (blanching redness)

Mediators: Histamine, prostaglandins, bradykinin, nitric oxide

Examples: Viral exanthems, drug reactions, flushing

Vasculitis

Mechanism: Inflammation of vessel walls causes vessel damage and extravasation of blood (non-blanching)

Mediators: Immune complexes, complement, neutrophils

Examples: Henoch-Schönlein purpura, Kawasaki disease

Extravasation

Mechanism: Red blood cells leak from vessels due to thrombocytopenia, coagulopathy, or vessel fragility

Cause: Platelet dysfunction, clotting factor deficiency, sepsis

Examples: Idiopathic thrombocytopenic purpura, meningococcemia, leukemia

4. Inflammatory Mechanisms

Inflammatory Pathway	Key Mediators	Clinical Features	Pediatric Conditions
Th2-predominant	Interleukin-4, Interleukin-13, Interleukin-5, IgE	Eczematous changes, pruritus, eosinophilia, elevated IgE	Atopic dermatitis, allergic contact dermatitis
Th17-predominant	Interleukin-17, Interleukin-22, Interleukin-23	Epidermal hyperproliferation, scaling, plaque formation	Psoriasis, seborrheic dermatitis
Th1-predominant	Interferon-gamma, Tumor necrosis factor-alpha	Granuloma formation, delayed hypersensitivity	Granuloma annulare, sarcoidosis (rare in children)
Autoinflammatory	Interleukin-1, Interleukin-6, inflammasomes	Periodic fevers, urticarial eruptions, systemic inflammation	Periodic fever syndromes, systemic juvenile idiopathic arthritis

Mechanism-Based Approach to Common Pediatric Rashes

Condition	Primary Mechanism	Why It Looks This Way	Treatment Implication
Viral exanthem (nonspecific)	Host immune response to viral antigens; circulating immune complexes and cytokine release	Diffuse maculopapular eruption reflects widespread endothelial activation; often appears as fever resolves when immune response peaks	Supportive care; self-limited as immune clearance progresses
Varicella (chickenpox)	Direct keratinocyte infection by varicella-zoster virus; ballooning degeneration creates vesicles	Lesions in various stages (“crops”) reflect successive waves of viremia; centripetal distribution follows viral spread	Antivirals if immunocompromised or complicated; supportive care; vaccination prevents disease
Urticaria	Type I hypersensitivity; mast cell degranulation with histamine release	Wheals form from rapid dermal edema; transient nature (less than 24 hours per lesion) reflects histamine metabolism	Antihistamines block H1 receptors; identify and avoid triggers
Atopic dermatitis	Epidermal barrier dysfunction (filaggrin deficiency) plus Th2 immune dysregulation	Dry, eczematous skin from barrier defects; pruritus from Th2 cytokines; secondary infection from scratching and colonization	Restore barrier with emollients; reduce inflammation with topical corticosteroids; control Staphylococcus aureus colonization
Impetigo	Superficial bacterial infection (Staphylococcus aureus or Streptococcus pyogenes); bacterial enzymes break down desmosomes	Honey-crusted lesions from dried serous exudate; bullous variant from staphylococcal exfoliative toxin acting locally	Topical antibiotics for limited disease; systemic antibiotics for extensive involvement
Henoch-Schönlein purpura (IgA vasculitis)	Type III hypersensitivity; IgA immune complex deposition in small vessel walls	Palpable purpura from vessel wall inflammation and extravasation; gravity-dependent distribution (lower extremities, buttocks)	Supportive care; corticosteroids may help joint symptoms; monitor for renal involvement
Kawasaki disease	Systemic vasculitis of medium-sized vessels; immune activation with coronary artery predilection	Polymorphous rash from vasculitis; mucosal changes from mucosal vessel inflammation; desquamation in convalescence	Intravenous immunoglobulin reduces coronary artery aneurysm risk; aspirin for anti-inflammatory and antiplatelet effects
Scarlet fever	Streptococcal pyrogenic exotoxins cause systemic cytokine release and capillary damage	Sandpaper texture from punctate papules; circumoral pallor from sparing of that vascular territory; desquamation in recovery	Antibiotics to eradicate Group A Streptococcus and prevent complications
Scabies	Sarcoptes scabiei mite burrows in stratum corneum; delayed hypersensitivity to mite proteins	Intense pruritus from Type IV hypersensitivity (4-6 week delay in primary infection); burrows from mite tunneling	Topical permethrin or oral ivermectin kills mites; treat all close contacts simultaneously
Drug eruption (morbilliform)	Type IV delayed hypersensitivity; T cells recognize drug or drug-modified proteins	Morbilliform pattern from widespread T cell activation; typically appears 7-14 days after drug exposure (shorter if previously sensitized)	Discontinue offending drug; supportive care; symptoms resolve over 1-2 weeks after drug cessation

Often Overlooked Mechanism: The Post-Viral Exanthem

Many rashes attributed to “viral exanthems” actually appear as the child is recovering and fever has resolved. This seemingly paradoxical timing occurs because the rash represents the peak of the immune response, not the height of viral replication. This explains why roseola (caused by human herpesvirus 6) classically presents with rash appearing after defervescence — the rash marks immune clearance, not ongoing infection. Understanding this mechanism helps reassure parents that the rash appearing as fever resolves is actually a sign of recovery, not disease progression.

Developmental Pearl: Why Neonates Get Different Rashes

The neonatal immune system is characterized by Th2 skewing and reduced Th1 responses, immature dendritic cell function, and passive maternal antibody presence. This explains several unique neonatal phenomena: erythema toxicum neonatorum (exaggerated response to normal skin colonization), increased susceptibility to disseminated herpes simplex virus infection, and relative protection from some infections through maternal antibodies. The transition from fetal to postnatal immune environment occurs over the first months of life, which is why certain conditions are unique to the neonatal period.

The Blanching Test: Understanding Its Pathophysiology

Clinical Application: The blanching test (pressing on a lesion to see if redness disappears) distinguishes between vasodilation and extravasation.

Blanching rash: Caused by vasodilation — blood is still within vessels and can be temporarily displaced by pressure. Examples include viral exanthems, urticaria, and erythema
Non-blanching rash: Caused by blood outside vessels (extravasation) — red blood cells in tissue cannot be displaced by pressure. Examples include petechiae, purpura, and ecchymoses

Critical Point: Any febrile child with a non-blanching rash must be evaluated urgently for meningococcemia and other causes of disseminated intravascular coagulation. While many causes of petechiae are benign (mechanical petechiae from coughing, viral-associated thrombocytopenia), the consequences of missing meningococcemia are catastrophic.

Complications of Skin Rashes

Complication	Mechanism	Associated Conditions	Prevention/Management
Secondary bacterial infection	Disrupted skin barrier allows bacterial entry; scratching introduces pathogens	Atopic dermatitis, varicella, scabies, any pruritic rash	Minimize scratching; maintain skin hygiene; topical or systemic antibiotics when infected
Scarring	Deep tissue damage beyond the basement membrane; abnormal wound healing	Severe varicella, deep bacterial infections, severe acne, excoriated lesions	Early treatment of primary condition; minimize scratching; wound care
Post-inflammatory hyperpigmentation	Inflammation stimulates melanocyte activity; melanin deposited in dermis	Any inflammatory skin condition; more common in darker skin tones	Sun protection; treat underlying inflammation; generally fades over months
Eczema herpeticum	Herpes simplex virus superinfection in compromised skin barrier	Atopic dermatitis (most common), other eczematous conditions	Urgent antiviral therapy; can be life-threatening if disseminated

3. History Taking

A comprehensive approach to eliciting the pediatric rash history

Red Flags — Require Urgent Evaluation

Non-blanching rash (petechiae/purpura) — Meningococcemia, disseminated intravascular coagulation, leukemia
Ill-appearing or toxic child — Sepsis, meningitis, toxic shock syndrome
High fever with rash — Kawasaki disease, serious bacterial infection
Mucosal involvement with skin sloughing — Stevens-Johnson syndrome, toxic epidermal necrolysis
Rapidly spreading erythema with systemic symptoms — Necrotizing fasciitis, cellulitis with sepsis

Vesicular rash in a neonate — Neonatal herpes simplex virus infection (life-threatening)
Rash with joint swelling and fever for more than 5 days — Kawasaki disease, systemic juvenile idiopathic arthritis
Purpuric rash with abdominal pain — Henoch-Schönlein purpura with potential intussusception
Widespread blistering or skin detachment — Staphylococcal scalded skin syndrome, Stevens-Johnson syndrome
Erythroderma (greater than 90% body surface area involved) — Drug reaction, ichthyosis, psoriasis flare

Systematic History: The “RASHES” Approach

Use the mnemonic “RASHES” to ensure comprehensive history taking for any pediatric rash:

R — Rash characteristics: When did it start? Where did it begin? How has it spread? What does it look like (description from parent)? Does it come and go or is it constant? Does it blanch with pressure?
A — Associated symptoms: Fever? Itching? Pain? Cough, runny nose, or other respiratory symptoms? Vomiting or diarrhea? Joint pain? Lethargy or irritability? Difficulty breathing?
S — Sick contacts and exposures: Anyone else sick at home, daycare, or school? Recent travel? New foods, medications, or products? Animal or insect exposure? Outdoor activities?
H — History (medical and family): Previous similar rashes? Known allergies or atopy? Eczema, asthma, or allergic rhinitis? Immunization status? Immunocompromised state? Family history of skin conditions?
E — Evolution and timeline: How has the rash changed over time? What treatments have been tried? Any response to antipyretics, antihistamines, or topical treatments? Getting better or worse?
S — Systemic review and severity: Is the child eating and drinking normally? Activity level? Urine output? Any signs of dehydration? How ill does the child appear to the caregiver?

Targeted Questions by Suspected Cause

Suspected Cause	Key Features	Ask This Question
Viral exanthem	Prodromal illness, fever preceding or with rash, diffuse maculopapular eruption	“Did your child have a fever or cold symptoms before the rash appeared? Is anyone else at daycare or school sick?”
Kawasaki disease	Fever for 5 or more days, conjunctival injection, oral changes, extremity changes, cervical lymphadenopathy	“How many days has the fever lasted? Are the eyes red without discharge? Are the lips cracked or the tongue red? Are the hands or feet swollen or peeling?”
Urticaria (hives)	Transient wheals, intense pruritus, individual lesions lasting less than 24 hours	“Do the individual spots come and go, or do they stay in the same place? How long does each spot last? Any new foods, medications, or products in the past few days?”
Drug eruption	Temporal relationship to medication, morbilliform pattern, may have mucosal involvement	“Has your child started any new medications in the past 2 weeks, including antibiotics, over-the-counter medicines, or supplements?”
Atopic dermatitis	Chronic or relapsing course, pruritus, flexural involvement (older children), personal or family history of atopy	“Does your child or anyone in the family have eczema, asthma, or hay fever? Does the rash get worse with certain triggers like dry weather, sweating, or specific products?”
Scarlet fever	Sandpaper rash, sore throat, strawberry tongue, circumoral pallor	“Has your child had a sore throat or difficulty swallowing? Does the rash feel rough like sandpaper when you touch it?”
Henoch-Schönlein purpura	Palpable purpura on lower extremities and buttocks, joint pain, abdominal pain	“Are the spots raised when you touch them? Does your child have any tummy pain, joint pain, or blood in the stool or urine?”
Scabies	Intense nocturnal pruritus, web spaces and wrists affected, household contacts itching	“Is the itching worse at night? Is anyone else in the household itching? Can you see any tiny lines or tracks on the skin?”
Impetigo	Honey-crusted lesions, often around nose and mouth, may follow minor trauma	“Did the rash start as a small sore or blister that then spread? Are there yellow or honey-colored crusts on the lesions?”
Varicella (chickenpox)	Vesicular rash in crops, different stages simultaneously, pruritic	“Has your child been vaccinated against chickenpox? Are the spots in different stages — some flat, some raised, some with blisters, some crusted over?”
Hand-foot-mouth disease	Oral ulcers, vesicles on palms and soles, summer and fall seasonality	“Does your child have sores inside the mouth? Is there a rash on the palms of the hands or soles of the feet? Is your child refusing to eat or drink?”
Tinea (ringworm)	Annular scaly plaque with central clearing, contact with animals or other children	“Does the rash have a ring shape with clearing in the middle? Does your child have contact with cats, dogs, or other animals? Does anyone else have a similar rash?”
Meningococcemia	Rapidly progressive petechiae or purpura, fever, ill appearance	“Is the rash spreading quickly? Does your child seem very unwell or different from usual? Is there neck stiffness or sensitivity to light?”

Pediatric-Specific History Components

Birth and Neonatal History

Particularly important for rashes presenting in the first months of life:

History Element	Relevance to Rash	Specific Conditions
Gestational age	Premature infants have more fragile skin and immature immune systems	Increased risk of skin breakdown, infections, iatrogenic rashes
Maternal infections	TORCH infections can cause congenital rashes	Congenital rubella (blueberry muffin rash), congenital syphilis, cytomegalovirus, toxoplasmosis
Maternal herpes simplex virus status	Risk of neonatal herpes simplex virus infection	Neonatal herpes simplex virus — vesicular rash is a medical emergency
Delivery complications	Trauma-related petechiae, instrumentation marks	Forceps marks, vacuum bruising, traumatic petechiae
Nursery exposures	Healthcare-associated infections	Staphylococcal infections, candidiasis

Immunization History

Vaccine-Preventable Causes of Rash

Measles: Ask about MMR vaccination status
Rubella: MMR vaccination
Varicella: Varicella vaccine status
Meningococcus: Meningococcal vaccine status

Vaccine-Related Rashes

Post-MMR rash: Mild maculopapular rash 7-10 days after vaccination
Post-varicella vaccine: Mild varicelliform rash
Injection site reactions: Local erythema and induration

Developmental and Growth History

Relevant for chronic skin conditions and syndromic diagnoses:

Growth parameters: Failure to thrive may suggest underlying immunodeficiency, malignancy, or chronic disease
Developmental milestones: Syndromic conditions with skin findings often have developmental implications
Previous hospitalizations: May indicate chronic illness or immunocompromised state

Feeding History

Important for infants and young children:

Breastfeeding versus formula: Maternal diet can affect breastfed infants with allergies
Introduction of solids: Timing of new food introduction relative to rash onset
Food refusal: Oral involvement may cause decreased intake (hand-foot-mouth disease, Stevens-Johnson syndrome)

Medication and Exposure History

Medications That Commonly Cause Rash

Antibiotics (especially penicillins, sulfonamides, cephalosporins) — Most common cause of drug eruptions in children; morbilliform rash typically appears 7-14 days after starting
Nonsteroidal anti-inflammatory drugs — Urticaria, angioedema, morbilliform eruptions
Anticonvulsants (phenytoin, carbamazepine, lamotrigine) — Can cause severe reactions including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms
Allopurinol — High risk of severe cutaneous adverse reactions
Amoxicillin during Epstein-Barr virus infection — Characteristic morbilliform eruption in nearly 100% of cases

Environmental Exposures

New detergents, soaps, lotions: Contact dermatitis
Plants (poison ivy, oak, sumac): Allergic contact dermatitis
Insect bites: Papular urticaria, local reactions
Animals: Tinea from cats and dogs, cat scratch disease
Swimming pools: Hot tub folliculitis, swimmer’s itch
Travel: Endemic infections, unusual exposures
Sun exposure: Photosensitive eruptions, sunburn

Social History

Social Factor	Relevance	Conditions to Consider
Daycare or school attendance	High exposure to viral and bacterial pathogens; outbreaks common	Viral exanthems, hand-foot-mouth disease, impetigo, scabies, head lice
Household contacts with similar symptoms	Suggests contagious etiology	Scabies (all family members itching), viral infections, streptococcal infections
Recent travel	Exposure to endemic infections or unusual vectors	Measles (unvaccinated travelers), dengue, Zika, leishmaniasis, rickettsial diseases
Pet exposure	Zoonotic infections, allergic reactions	Tinea (cats, dogs, guinea pigs), cat scratch disease, flea bites
Outdoor activities	Tick exposure, plant contact	Lyme disease, Rocky Mountain spotted fever, poison ivy contact dermatitis
Sports participation	Skin-to-skin contact, shared equipment	Herpes gladiatorum (wrestling), tinea corporis, molluscum contagiosum

History-Taking Pearl: The Photo Review

Parents often photograph their child’s rash, especially if it has changed by the time they reach medical care. Always ask to see photos taken at home — these can be invaluable for:

Documenting transient lesions like urticaria that may have resolved
Showing the evolution of the rash over time
Capturing the original distribution before treatment was applied
Identifying lesions that the child has scratched away

Photos with a timestamp can help establish the timeline and rate of progression, which is critical for conditions like meningococcemia where rapid spread indicates severity.

4. Physical Examination

A systematic head-to-toe approach for pediatric rash

Systematic Framework: Use the “Head to Toe, Don’t Forget the Folds” approach for complete examination of children presenting with rash. Remember to examine ALL skin surfaces including scalp, behind ears, between fingers and toes, axillae, groin, and diaper area.

General Inspection

Begin with a global assessment before focusing on the skin:

Overall appearance: Well-appearing, mildly ill, or toxic? This is the most critical initial assessment — a toxic-appearing child with a rash requires immediate resuscitation and evaluation
Activity level: Playing normally? Irritable? Lethargic? Consolable or inconsolable?
Interaction: Age-appropriate interaction with caregivers and environment? Eye contact?
Color: Pink, pale, mottled, cyanotic, or jaundiced?
Hydration: Moist mucous membranes? Tears when crying? Skin turgor?
Respiratory effort: Any signs of respiratory distress that might indicate anaphylaxis or systemic illness?
Nutritional status: Well-nourished or signs of failure to thrive?

Vital Signs by Age

Accurate vital signs are essential — fever with rash changes the differential significantly.

Age Group	Heart Rate (beats per minute)	Respiratory Rate (breaths per minute)	Systolic Blood Pressure (mmHg)	Temperature
Neonate (0-28 days)	100-160	30-60	60-90	36.5-37.5°C
Infant (1-12 months)	100-150	25-40	80-100	36.5-37.5°C
Toddler (1-3 years)	90-140	20-30	90-105	36.5-37.5°C
Preschool (3-5 years)	80-120	20-25	95-110	36.5-37.5°C
School-age (6-12 years)	70-110	18-22	100-120	36.5-37.5°C
Adolescent (13-18 years)	60-100	12-20	100-130	36.5-37.5°C

Vital Sign Red Flags in Children with Rash

Tachycardia out of proportion to fever: May indicate sepsis, dehydration, or shock
Hypotension: Late sign of shock — do not wait for this to act
Fever greater than 39°C with petechial rash: High risk for meningococcemia
Fever for 5 or more days with rash: Must consider Kawasaki disease
Capillary refill greater than 3 seconds: Poor perfusion — concerning for sepsis

Growth Parameters

Plot on appropriate growth charts — particularly important for chronic skin conditions:

Weight: Failure to thrive may suggest underlying immunodeficiency, malignancy, or severe chronic illness
Height/Length: Growth failure associated with systemic disease
Head circumference (under 2 years): Relevant for syndromic conditions with skin manifestations
Body mass index (older children): Nutritional status assessment

Systematic Skin Examination

Step 1: Morphology Assessment

Identify the PRIMARY lesion type:

Examine For	How to Assess	What to Document
Lesion type	Visual inspection and palpation	Macule, papule, vesicle, pustule, plaque, nodule, wheal, petechiae, purpura
Size	Measure with ruler if possible	Diameter in millimeters or centimeters; range if variable
Color	Visual inspection in good lighting	Erythematous, violaceous, hyperpigmented, hypopigmented, skin-colored
Shape	Observe outline	Round, oval, annular (ring-shaped), linear, serpiginous, irregular
Border	Examine edges	Well-defined, ill-defined, raised, flat
Surface	Palpation and inspection	Smooth, rough, scaly, crusted, excoriated, lichenified
Blanching	Apply firm pressure with finger or glass slide (diascopy)	Blanching (blood in vessels) versus non-blanching (extravasated blood)

Step 2: Distribution Assessment

Distribution Patterns

Generalized: Widespread involvement
Localized: Confined to one area
Symmetric: Bilateral, mirror-image
Asymmetric: One-sided or irregular
Central (truncal): Body predominant
Peripheral (acral): Hands, feet predominant
Flexural: Antecubital, popliteal fossae
Extensor: Elbows, knees
Dermatomal: Following nerve distribution
Sun-exposed: Face, neck, arms, legs

Configuration Patterns

Discrete: Individual separate lesions
Confluent: Lesions merging together
Clustered: Groups of lesions (herpetiform)
Linear: In a line (contact, Koebner phenomenon)
Annular: Ring-shaped
Target/iris: Concentric rings
Reticular: Lacy, net-like pattern
Zosteriform: Following dermatome

Step 3: Regional Examination

Body Region	What to Examine	Conditions Suggested by Findings
Scalp	Part hair to examine skin; look for scaling, crusting, pustules, hair loss	Tinea capitis (scaling with hair loss), seborrheic dermatitis (cradle cap), psoriasis, pediculosis
Face	Cheeks, perioral area, eyelids; note any facial sparing or specific patterns	Slapped cheek (erythema infectiosum), malar rash (lupus), perioral dermatitis, impetigo
Eyes	Conjunctival injection, discharge, periorbital edema	Kawasaki disease (bilateral non-exudative), measles (conjunctivitis with Koplik spots)
Ears	Pinna, behind ears, external auditory canal	Seborrheic dermatitis (behind ears), psoriasis, contact dermatitis (earrings)
Oral cavity	Lips, buccal mucosa, tongue, palate, pharynx	Koplik spots (measles), strawberry tongue (scarlet fever, Kawasaki), oral ulcers (hand-foot-mouth, Stevens-Johnson syndrome)
Neck	Anterior and posterior neck, cervical lymph nodes	Lymphadenopathy (Kawasaki — unilateral cervical >1.5 cm), viral infections
Trunk	Chest, back, abdomen; note any truncal predominance	Viral exanthems (central distribution), pityriasis rosea (herald patch on trunk)
Axillae	Skin folds, lymph nodes	Intertrigo, contact dermatitis, lymphadenopathy
Arms and legs	Extensors, flexors, distribution pattern	Henoch-Schönlein purpura (lower extremities), atopic dermatitis (flexural), psoriasis (extensor)
Hands and feet	Palms, soles, between fingers and toes, nail folds	Hand-foot-mouth disease, scabies (web spaces), Kawasaki (edema, desquamation), tinea
Groin and buttocks	Inguinal folds, gluteal cleft, perianal area	Diaper dermatitis, candidiasis, Henoch-Schönlein purpura (buttocks), streptococcal perianal disease
Nails	Nail plate, nail bed, periungual tissue	Psoriasis (pitting), fungal infection, Beau’s lines (previous illness), splinter hemorrhages

Special Examination Techniques

Technique	How to Perform	What It Tests	Interpretation
Diascopy (blanching test)	Press a glass slide firmly against the lesion	Whether blood is intravascular or extravasated	Blanching = blood in vessels (erythema); Non-blanching = blood outside vessels (petechiae, purpura)
Nikolsky sign	Apply lateral pressure to normal-appearing skin near a blister	Epidermal fragility and intraepidermal cleavage	Positive (skin sloughs) = staphylococcal scalded skin syndrome, Stevens-Johnson syndrome, pemphigus
Auspitz sign	Remove scale from a plaque lesion	Punctate bleeding points beneath scale	Positive = psoriasis (capillaries exposed when scale removed)
Darier sign	Stroke or rub a lesion firmly	Mast cell degranulation	Positive (urtication and erythema) = mastocytosis, urticaria pigmentosa
Dermographism	Stroke normal skin with a tongue depressor	Skin reactivity to pressure	Positive (wheal and flare) = physical urticaria, atopic tendency
Wood’s lamp examination	Examine skin under ultraviolet light in a dark room	Fluorescence of certain organisms and pigment changes	Coral red = erythrasma; Blue-green = Pseudomonas; Enhanced hypopigmentation = vitiligo, tuberous sclerosis (ash leaf spots)

Associated Systemic Findings

System	Findings to Look For	Associated Conditions
Lymph nodes	Cervical, axillary, inguinal lymphadenopathy; size, tenderness, mobility	Kawasaki (unilateral cervical >1.5 cm), viral infections, cat scratch disease, malignancy
Joints	Swelling, warmth, tenderness, range of motion	Henoch-Schönlein purpura, juvenile idiopathic arthritis, acute rheumatic fever, reactive arthritis
Abdomen	Hepatosplenomegaly, tenderness, guarding	Infectious mononucleosis, leukemia, Henoch-Schönlein purpura (intussusception risk)
Cardiovascular	Murmurs, tachycardia, hypotension, capillary refill	Kawasaki disease (coronary involvement), sepsis, toxic shock syndrome
Neurological	Meningismus, altered mental status, focal deficits	Meningococcemia, encephalitis, cerebral vasculitis
Respiratory	Stridor, wheezing, respiratory distress	Anaphylaxis, angioedema, viral respiratory infection with exanthem

Expected Findings by Common Etiology

Condition	Primary Lesion	Distribution	Key Examination Findings
Viral exanthem (nonspecific)	Erythematous macules and papules	Generalized, often trunk predominant	Blanching; well-appearing child; may have lymphadenopathy
Varicella	Vesicles on erythematous base (“dewdrop on rose petal”)	Centripetal (trunk > extremities); lesions in different stages	Pruritic; crops of lesions; may involve scalp and mucous membranes
Hand-foot-mouth disease	Vesicles, papules	Hands (palms), feet (soles), oral mucosa, buttocks	Oral ulcers; vesicles may be oval and follow skin lines; usually mild illness
Scarlet fever	Fine papular rash (“sandpaper” texture)	Generalized; accentuated in flexural creases (Pastia lines)	Circumoral pallor; strawberry tongue; flushed cheeks; pharyngitis
Kawasaki disease	Polymorphous (various morphologies)	Generalized; often perineal accentuation	Fever ≥5 days; bilateral conjunctival injection; lip/tongue changes; extremity changes; cervical lymphadenopathy
Henoch-Schönlein purpura	Palpable purpura (non-blanching, raised)	Lower extremities and buttocks (gravity-dependent)	Joint swelling; abdominal tenderness; normal platelet count
Urticaria	Wheals (raised, erythematous, edematous)	Variable; may be generalized or localized	Blanching; individual lesions transient (<24 hours); intensely pruritic
Atopic dermatitis	Eczematous plaques, papules	Infants: face, extensors; Older children: flexural	Xerosis (dry skin); lichenification; excoriations; pruritus
Impetigo	Vesicles, pustules, honey-colored crusts	Face (perioral, perinasal); sites of minor trauma	Golden/honey crusts; may have satellite lesions; regional lymphadenopathy
Tinea corporis	Annular scaly plaque with raised border	Anywhere on body; often exposed areas	Central clearing; advancing scaly edge; may have multiple lesions
Scabies	Papules, vesicles, burrows	Web spaces, wrists, axillae, waistline, genitals; infants: head, palms, soles	Burrows; excoriations; may see mite at end of burrow; intense pruritus
Meningococcemia	Petechiae, purpura (may become hemorrhagic and necrotic)	Generalized; may start as blanching maculopapular rash	Ill-appearing; fever; rapid progression; may have meningismus

Important Teaching Point

The well-appearing child with a rash: In most pediatric rash presentations, the child will appear well and the physical examination (beyond the skin) will be unremarkable. The majority of rashes in childhood are benign viral exanthems that resolve spontaneously. However, this should never lead to complacency — always perform the blanching test, assess vital signs, and look for red flag features. The goal is to identify the minority of children who require urgent intervention while appropriately reassuring the majority.

Examination Pearl: The Uncooperative Child

Examining a frightened or uncooperative child requires patience and strategy:

Start with observation from a distance — you can assess general appearance, color, activity, and even see some of the rash before touching the child
Examine in the parent’s lap when possible
Leave invasive examinations (throat, ears) until last
Use distraction techniques — examine a stuffed animal first, use toys, engage siblings
For the blanching test, use a clear drinking glass or the side of a pen — these may be less frightening than pressing with your finger
Document what you CAN see even if complete examination is not possible

5. Differential Diagnosis

Systematic approach organized by probability, duration, and clinical features

The differential diagnosis for pediatric rash is broad, encompassing infectious, inflammatory, allergic, and systemic conditions. A systematic approach based on probability, duration, morphology, and associated features allows efficient narrowing of the differential. Always consider the child’s age, immunization status, and overall clinical appearance when generating your differential.

Acute Rash (Duration: Less than 2 weeks)

Probability	Condition	Key Features	Red Flags
COMMON (approximately 70%)	Viral exanthem (nonspecific)	Maculopapular rash; preceded by or concurrent with fever; well-appearing child	High fever with ill appearance; petechiae
	Urticaria (acute)	Transient wheals; intense pruritus; individual lesions last less than 24 hours	Angioedema of lips, tongue, or throat; respiratory distress; hypotension
	Viral upper respiratory infection with rash	Concurrent cough, rhinorrhea; mild maculopapular eruption	Respiratory distress; toxic appearance
	Insect bite reactions	Grouped papules; exposed areas; pruritic; may have central punctum	Extensive swelling; systemic symptoms; bullous reactions
	Contact dermatitis (irritant or allergic)	Erythematous, possibly vesicular; geometric pattern; exposed areas	Extensive involvement; secondary infection
	Impetigo	Honey-crusted lesions; perioral and perinasal; spreads locally	Extensive involvement; systemic symptoms; bullous form in neonates
LESS COMMON (approximately 20%)	Hand-foot-mouth disease	Oral ulcers; vesicles on palms, soles, buttocks; summer and fall	Severe dehydration from oral pain; neurological symptoms (rare enterovirus 71)
	Varicella (chickenpox)	Vesicles in crops; different stages simultaneously; pruritic; centripetal	Immunocompromised host; pneumonia; encephalitis; secondary bacterial infection
	Scarlet fever	Sandpaper rash; pharyngitis; strawberry tongue; circumoral pallor	Difficulty swallowing; drooling; neck swelling
	Erythema infectiosum (fifth disease)	Slapped cheek appearance; lacy reticular rash on extremities; child well when rash appears	Aplastic crisis in sickle cell disease; hydrops fetalis if pregnant contact
	Roseola infantum	High fever for 3-5 days; rash appears as fever resolves; infants 6-24 months	Febrile seizures; bulging fontanelle
	Drug eruption (morbilliform)	Maculopapular; 7-14 days after starting medication; trunk predominant	Mucosal involvement; skin pain; blistering; facial edema; systemic symptoms
UNCOMMON BUT SERIOUS (approximately 10%)	Meningococcemia	Petechiae and purpura; rapidly progressive; ill-appearing; fever	ALL presentations are red flags — immediate treatment required
	Kawasaki disease	Fever ≥5 days; polymorphous rash; conjunctival injection; oral changes; extremity changes	Coronary artery involvement; cardiac dysfunction; shock
	Stevens-Johnson syndrome	Target lesions; mucosal involvement (≥2 sites); skin pain; preceding drug exposure	All presentations require urgent evaluation and management
	Staphylococcal scalded skin syndrome	Diffuse erythema; skin tenderness; Nikolsky sign positive; perioral crusting	All presentations require urgent evaluation; fluid and electrolyte losses
	Toxic shock syndrome	Diffuse erythroderma; fever; hypotension; multiorgan involvement	All presentations are emergencies requiring immediate resuscitation
	Neonatal herpes simplex virus	Vesicular rash in neonate; may have clustered lesions; can be disseminated	All neonatal vesicular rashes require immediate evaluation and empiric treatment

Chronic Rash (Duration: Greater than 6 weeks)

Step-by-Step Approach to Chronic Pediatric Rash:

Step 1: Is there an underlying pattern? — Eczematous, papulosquamous, infectious, or other
Step 2: Consider the “Common Four” in chronic pediatric rash — Atopic dermatitis, tinea infections, psoriasis, and chronic urticaria
Step 3: Assess distribution — Flexural (atopic), extensor (psoriasis), annular (tinea), diffuse (urticaria)
Step 4: If initial diagnosis unclear, consider dermatology referral for biopsy and specialized testing

Probability	Condition	Approximate Frequency	Key Distinguishing Features
COMMON	Atopic dermatitis	15-20% of children	Chronic relapsing course; xerosis; pruritus; age-dependent distribution; personal or family history of atopy
	Tinea infections (corporis, capitis, pedis)	10-15% of children	Annular scaly plaques with central clearing; tinea capitis with hair loss and scaling; positive potassium hydroxide preparation
	Chronic urticaria	1-3% of children	Wheals lasting less than 24 hours each; greater than 6 weeks duration; often no identifiable trigger
	Molluscum contagiosum	5-10% of children	Umbilicated flesh-colored papules; spread by autoinoculation; more extensive in atopic children
LESS COMMON	Psoriasis	1-2% of children	Well-demarcated erythematous plaques with silvery scale; extensor surfaces; nail pitting; may have guttate form
	Pityriasis rosea	Common in school-age and adolescents	Herald patch followed by “Christmas tree” pattern; oval lesions following skin lines; self-limited (6-8 weeks)
	Seborrheic dermatitis	Common in infants (cradle cap) and adolescents	Greasy yellow scales; scalp, face, and intertriginous areas; bimodal age distribution
	Warts (verrucae)	10-20% of school-age children	Rough papules and plaques; common on hands and feet; plantar warts may be painful
UNCOMMON	Vitiligo	0.5-1% of children	Depigmented patches; often symmetric; may be associated with autoimmune conditions
	Lichen planus	Rare in children	Purple, polygonal, pruritic papules; Wickham striae; may involve oral mucosa
	Morphea (localized scleroderma)	Rare	Indurated plaques; lilac ring at active border; may cause growth disturbance if over joints
	Cutaneous mastocytosis	Rare	Tan-brown macules and papules; positive Darier sign; may have systemic symptoms with mast cell degranulation

Age-Based Differential Approach

Age Group	Most Common Causes	Important Not to Miss
Neonate (0-28 days)	Erythema toxicum neonatorum, milia, neonatal acne, seborrheic dermatitis, transient neonatal pustular melanosis	Neonatal herpes simplex virus, congenital infections (TORCH), bacterial sepsis, epidermolysis bullosa, incontinentia pigmenti
Infant (1-12 months)	Atopic dermatitis, seborrheic dermatitis, diaper dermatitis, viral exanthems, roseola	Kawasaki disease (peak incidence), Langerhans cell histiocytosis, scabies, candidiasis
Toddler (1-3 years)	Viral exanthems, hand-foot-mouth disease, impetigo, atopic dermatitis, urticaria	Kawasaki disease, Henoch-Schönlein purpura, meningococcemia, cellulitis
Preschool (3-5 years)	Viral exanthems, impetigo, tinea, molluscum contagiosum, urticaria	Henoch-Schönlein purpura, Kawasaki disease (less common), streptococcal infections
School-age (6-12 years)	Atopic dermatitis (flexural), tinea, pityriasis rosea, warts, guttate psoriasis	Henoch-Schönlein purpura (peak incidence 4-6 years), drug eruptions, juvenile dermatomyositis
Adolescent (13-18 years)	Acne vulgaris, pityriasis rosea, tinea, contact dermatitis, psoriasis	Drug eruptions, sexually transmitted infections, systemic lupus erythematosus, dermatomyositis

Anatomical Approach to Pediatric Rash

Head and Face

Scalp: Tinea capitis, seborrheic dermatitis, psoriasis, pediculosis

Face: Impetigo, atopic dermatitis (infants), acne, erythema infectiosum (slapped cheek), lupus malar rash

Perioral: Impetigo, perioral dermatitis, herpes simplex, angular cheilitis

Trunk

Central: Viral exanthems, pityriasis rosea, drug eruptions, scarlet fever

Intertriginous: Candidiasis, intertrigo, inverse psoriasis, seborrheic dermatitis

Unilateral: Herpes zoster (rare in children), contact dermatitis

Extremities

Flexural: Atopic dermatitis (older children), intertrigo

Extensor: Psoriasis, atopic dermatitis (infants), keratosis pilaris

Lower extremities: Henoch-Schönlein purpura, erythema nodosum, vasculitis

Hands, Feet, and Diaper Area

Palms and soles: Hand-foot-mouth disease, erythema multiforme, secondary syphilis (adolescents)

Web spaces: Scabies, tinea pedis, dyshidrotic eczema

Diaper area: Irritant diaper dermatitis, candidiasis, psoriasis, perianal streptococcal disease

Morphology-Based Differential

Primary Morphology	Common Causes	Less Common but Important
Maculopapular	Viral exanthems, drug eruptions, scarlet fever, erythema infectiosum	Kawasaki disease, systemic juvenile idiopathic arthritis, early meningococcemia
Vesicular	Varicella, herpes simplex, hand-foot-mouth disease, contact dermatitis	Neonatal herpes simplex virus, eczema herpeticum, bullous impetigo, Stevens-Johnson syndrome
Pustular	Folliculitis, acne, erythema toxicum neonatorum (neonates)	Bacterial infection, pustular psoriasis, transient neonatal pustular melanosis
Petechial/Purpuric	Mechanical petechiae (coughing, vomiting), viral-associated thrombocytopenia	Meningococcemia, Henoch-Schönlein purpura, idiopathic thrombocytopenic purpura, leukemia, non-accidental injury
Urticarial (wheals)	Acute urticaria (infection-related, allergic), dermatographism	Urticarial vasculitis, serum sickness, autoinflammatory syndromes
Papulosquamous	Psoriasis, pityriasis rosea, tinea corporis, seborrheic dermatitis	Pityriasis lichenoides, secondary syphilis, mycosis fungoides (very rare in children)
Eczematous	Atopic dermatitis, contact dermatitis, seborrheic dermatitis	Scabies, dermatophyte infection, zinc deficiency, Langerhans cell histiocytosis
Annular	Tinea corporis, granuloma annulare, urticaria	Erythema migrans (Lyme disease), neonatal lupus, erythema marginatum (rheumatic fever)
Target lesions	Erythema multiforme, urticaria multiforme	Stevens-Johnson syndrome, fixed drug eruption

Drug-Induced Rash in Children

Drug or Drug Class	Type of Reaction	Typical Timing	Key Features
Penicillins and aminopenicillins	Morbilliform eruption (most common); urticaria; rarely anaphylaxis	7-14 days after starting (morbilliform); minutes to hours (urticaria)	Amoxicillin with Epstein-Barr virus infection causes rash in nearly 100% of cases
Sulfonamides (including trimethoprim-sulfamethoxazole)	Morbilliform; Stevens-Johnson syndrome or toxic epidermal necrolysis; fixed drug eruption	1-3 weeks (Stevens-Johnson syndrome); days (morbilliform)	Higher risk of severe reactions; avoid rechallenge after severe reaction
Cephalosporins	Morbilliform eruption; urticaria; cross-reactivity with penicillins (approximately 1-2%)	Variable	Similar presentation to penicillin reactions
Nonsteroidal anti-inflammatory drugs	Urticaria and angioedema; morbilliform; fixed drug eruption	Hours to days	May exacerbate chronic urticaria; cross-reactivity between different nonsteroidal anti-inflammatory drugs
Anticonvulsants (phenytoin, carbamazepine, lamotrigine, phenobarbital)	Morbilliform; Stevens-Johnson syndrome or toxic epidermal necrolysis; drug reaction with eosinophilia and systemic symptoms	2-8 weeks	Cross-reactivity between aromatic anticonvulsants; slow titration of lamotrigine reduces Stevens-Johnson syndrome risk
Vaccines	Local injection site reaction; mild morbilliform rash (especially measles-mumps-rubella)	Immediate (local); 7-10 days (measles-mumps-rubella rash)	Post-measles-mumps-rubella rash is not a contraindication to future doses

Red Flags for Severe Drug Reactions

The following features suggest Stevens-Johnson syndrome, toxic epidermal necrolysis, or drug reaction with eosinophilia and systemic symptoms — discontinue the suspected drug immediately and seek urgent specialist input:

Mucosal involvement (oral, ocular, genital) — ≥2 mucosal sites
Skin pain or tenderness out of proportion to visible findings
Blistering, erosions, or skin detachment
Nikolsky sign positive (skin sloughs with lateral pressure)
Facial edema
Fever, lymphadenopathy, and hepatitis (suggests drug reaction with eosinophilia and systemic symptoms)
Eosinophilia or atypical lymphocytes on blood count

Quick Reference: “If You See This, Think This”

Clinical Clue	Think This First	Next Step
Petechiae or purpura + fever + ill-appearing child	Meningococcemia	Immediate resuscitation; blood cultures; empiric antibiotics; do not wait for results
Fever ≥5 days + rash + red eyes + lip changes	Kawasaki disease	Urgent echocardiogram; intravenous immunoglobulin within 10 days of fever onset
Vesicular rash in neonate	Neonatal herpes simplex virus	Immediate acyclovir; herpes simplex virus polymerase chain reaction and cultures; ophthalmology consult
Slapped cheek appearance + lacy rash on extremities	Erythema infectiosum (parvovirus B19)	Reassurance (usually benign); warn pregnant contacts; check hemoglobin if child has hemoglobinopathy
High fever then rash as fever resolves in infant	Roseola infantum (human herpesvirus 6)	Reassurance; supportive care; usually no investigation needed
Sandpaper rash + sore throat + strawberry tongue	Scarlet fever	Rapid streptococcal antigen test or throat culture; treat with penicillin or amoxicillin
Palpable purpura on lower extremities + abdominal pain	Henoch-Schönlein purpura	Urinalysis; monitor for intussusception; supportive care; possible nephrology follow-up
Oral ulcers + vesicles on palms and soles	Hand-foot-mouth disease	Supportive care; ensure adequate hydration; infectious (exclude from daycare until afebrile)
Annular scaly plaque with central clearing	Tinea corporis	Potassium hydroxide preparation to confirm; topical antifungal treatment
Honey-crusted lesions around nose and mouth	Impetigo	Topical mupirocin for limited disease; oral antibiotics if extensive
Intense itching worse at night + family members itching	Scabies	Examine web spaces for burrows; treat patient and all household contacts simultaneously
Target lesions + mucosal involvement + recent drug	Stevens-Johnson syndrome	Stop offending drug immediately; urgent dermatology and ophthalmology; consider burn unit transfer
Diffuse erythema + skin tenderness + positive Nikolsky sign in infant	Staphylococcal scalded skin syndrome	Anti-staphylococcal antibiotics; supportive care; wound care
Herald patch followed by “Christmas tree” pattern	Pityriasis rosea	Reassurance (self-limited over 6-8 weeks); symptomatic treatment for pruritus

6. Diagnostic Investigations

A stepwise, cost-effective approach guided by clinical suspicion

The majority of pediatric rashes can be diagnosed clinically without laboratory investigation. However, certain presentations warrant targeted testing to confirm the diagnosis, exclude serious conditions, or guide management. The decision to investigate should be based on clinical suspicion, the child’s overall appearance, and the potential consequences of missing a serious diagnosis.

Key Principle: A well-appearing child with a typical presentation of a common condition (such as viral exanthem, urticaria, or impetigo) generally does not require laboratory investigation. Reserve testing for atypical presentations, ill-appearing children, suspected serious conditions, or when the diagnosis is unclear.

When to Investigate: Clinical Triggers

Clinical Scenario	Rationale for Investigation	Initial Tests to Consider
Petechial or purpuric rash	Exclude meningococcemia, thrombocytopenia, coagulopathy, leukemia	Full blood count with differential; blood cultures; coagulation studies; consider lumbar puncture
Fever ≥5 days with rash	Evaluate for Kawasaki disease	Full blood count; inflammatory markers (C-reactive protein, erythrocyte sedimentation rate); liver function tests; urinalysis; echocardiogram
Vesicular rash in neonate	Exclude neonatal herpes simplex virus infection	Herpes simplex virus polymerase chain reaction (swab lesion, blood, cerebrospinal fluid); viral culture; consider lumbar puncture
Ill-appearing child with rash	Exclude sepsis, toxic shock syndrome, invasive bacterial infection	Full blood count; blood cultures; inflammatory markers; blood gas; lactate; consider lumbar puncture
Suspected drug reaction with systemic features	Evaluate for drug reaction with eosinophilia and systemic symptoms or severe cutaneous adverse reaction	Full blood count with differential (eosinophilia); liver function tests; renal function; urinalysis
Recurrent or chronic urticaria	Evaluate for underlying triggers (rarely identified in children)	Consider: thyroid function tests; full blood count; inflammatory markers; allergy testing only if clear trigger suspected
Suspected autoimmune or connective tissue disease	Confirm diagnosis and assess organ involvement	Antinuclear antibody; complement levels; full blood count; renal function; urinalysis

Investigations for Common Conditions

Infectious Rashes

Suspected Condition	First-Line Investigation	What to Look For	Practical Points
Meningococcemia	Blood cultures; full blood count; coagulation studies; lumbar puncture (if safe)	Positive cultures; thrombocytopenia; disseminated intravascular coagulation; cerebrospinal fluid pleocytosis	Do NOT delay antibiotics for investigations; meningococcal polymerase chain reaction if available
Scarlet fever	Rapid streptococcal antigen test; throat culture	Positive for Group A Streptococcus	Clinical diagnosis often sufficient; negative rapid test should be confirmed with culture
Varicella (immunocompetent)	Usually none needed — clinical diagnosis	N/A	Polymerase chain reaction of vesicle fluid available if diagnosis uncertain
Neonatal herpes simplex virus	Herpes simplex virus polymerase chain reaction (lesion swab, blood, cerebrospinal fluid); viral culture	Positive polymerase chain reaction confirms infection	Start acyclovir empirically — do not wait for results; also check liver function tests and full blood count
Tinea (dermatophyte infections)	Potassium hydroxide preparation of skin scrapings; fungal culture	Hyphae on potassium hydroxide preparation; positive culture identifies organism	Scrape from active edge of lesion; tinea capitis requires oral treatment — confirm diagnosis
Scabies	Skin scraping from burrow examined microscopically	Mites, eggs, or fecal pellets (scybala)	Negative scraping does not exclude diagnosis — often treated empirically if clinical suspicion high
Impetigo	Usually none — clinical diagnosis; wound culture if treatment failure	Identifies organism and antibiotic sensitivities	Culture helpful for methicillin-resistant Staphylococcus aureus prevalence areas or treatment failure

Inflammatory and Immune-Mediated Rashes

Suspected Condition	First-Line Investigation	What to Look For	Practical Points
Kawasaki disease	Full blood count; C-reactive protein; erythrocyte sedimentation rate; liver function tests; urinalysis; echocardiogram	Thrombocytosis (later); elevated inflammatory markers; pyuria; coronary artery abnormalities	Echocardiogram is essential; repeat at 2 weeks and 6-8 weeks; treatment needed within 10 days of fever onset
Henoch-Schönlein purpura	Urinalysis (essential); full blood count; coagulation studies; renal function	Hematuria and proteinuria (nephritis); platelet count NORMAL (distinguishes from thrombocytopenia)	Repeat urinalysis weekly for 4-6 weeks, then monthly for 6 months to monitor for nephritis
Stevens-Johnson syndrome or toxic epidermal necrolysis	Full blood count; electrolytes; renal function; liver function tests	Assess for organ involvement; electrolyte disturbances from fluid losses	Skin biopsy may help confirm diagnosis; ophthalmology urgent referral
Drug reaction with eosinophilia and systemic symptoms	Full blood count with differential; liver function tests; renal function; urinalysis	Eosinophilia; atypical lymphocytes; elevated transaminases; renal impairment	Monitor organ function; symptoms may worsen after drug cessation initially
Juvenile dermatomyositis	Creatine kinase; aldolase; lactate dehydrogenase; antinuclear antibody; myositis-specific antibodies	Elevated muscle enzymes; positive antibodies	MRI of muscles; electromyography; muscle biopsy may be needed; screen for calcinosis
Systemic lupus erythematosus	Antinuclear antibody; double-stranded DNA antibody; complement (C3, C4); full blood count; renal function; urinalysis	Positive antibodies; low complement; cytopenias; proteinuria	Refer to pediatric rheumatology; assess for multiorgan involvement

Hematological Causes of Rash

Idiopathic Thrombocytopenic Purpura

Full blood count: Isolated thrombocytopenia (often less than 20 × 10⁹/L); other cell lines normal
Blood film: Large platelets; no abnormal cells
Bone marrow: Not routinely needed if typical presentation; consider if atypical features

Key point: Diagnosis of exclusion — ensure other causes of thrombocytopenia excluded

Leukemia

Full blood count: May show anemia, thrombocytopenia, neutropenia, or leukocytosis with blasts
Blood film: Blast cells visible
Bone marrow: Required for diagnosis
Other: Uric acid, lactate dehydrogenase, renal function (tumor lysis risk)

Red flags: Hepatosplenomegaly, lymphadenopathy, bone pain, fatigue, recurrent infections

Specialized Investigations

Investigation	Indication	What It Shows	Practical Considerations
Skin biopsy	Uncertain diagnosis; suspected vasculitis, blistering disorder, or malignancy; chronic unexplained rash	Histopathological diagnosis; direct immunofluorescence for autoimmune blistering diseases	Usually performed by dermatology; requires local anesthesia; consider sedation for young children
Wood’s lamp examination	Suspected tinea capitis, erythrasma, vitiligo, tuberous sclerosis (ash leaf spots)	Fluorescence patterns vary by condition	Performed in dark room; not all dermatophytes fluoresce (Trichophyton tonsurans does not)
Dermoscopy	Scabies (visualize burrows and mites); pigmented lesions; vascular lesions	Magnified view of skin structures	Non-invasive; requires training for interpretation; useful for scabies diagnosis
Patch testing	Suspected allergic contact dermatitis	Identifies specific allergens causing delayed hypersensitivity	Performed by dermatology or allergy; requires multiple visits; interpretation requires expertise
Skin prick testing	Suspected IgE-mediated allergy (urticaria with clear trigger)	Identifies specific allergens causing immediate hypersensitivity	Less useful for chronic urticaria (rarely identifies trigger); antihistamines must be stopped beforehand
Specific IgE blood tests	Alternative to skin prick testing; suspected food or environmental allergy	Quantifies allergen-specific IgE antibodies	Can be done while on antihistamines; results should be interpreted in clinical context
Tzanck smear	Suspected herpes simplex virus or varicella-zoster virus infection	Multinucleated giant cells suggest herpes virus infection	Rapid but does not distinguish between herpes simplex virus and varicella-zoster virus; polymerase chain reaction preferred

Pediatric-Specific Investigation Considerations

Special Considerations for Children

Minimize unnecessary blood draws: Combine tests when blood sampling is required; consider whether results will change management
Age-appropriate reference ranges: Pediatric normal values differ from adults — ensure laboratory uses appropriate ranges
Sedation considerations: Some procedures (biopsy, lumbar puncture) may require sedation or general anesthesia in young children
Parental anxiety: Explain the rationale for testing clearly; unnecessary investigation can increase anxiety
Pain management: Use topical anesthetics (such as lidocaine-prilocaine cream) before blood draws and procedures
Specimen collection challenges: Consider urine bags for infants; plan for small blood volumes in neonates

When Investigation Is NOT Necessary

Condition	Why Investigation Is Not Needed	Exception (When to Investigate)
Typical viral exanthem in well child	Self-limited; clinical diagnosis sufficient; no treatment required	Ill-appearing child; petechiae; immunocompromised host
Acute urticaria (less than 6 weeks)	Usually triggered by viral infection; self-limited; allergy testing rarely helpful	Anaphylaxis; clear food trigger for targeted testing; chronic urticaria (greater than 6 weeks)
Typical atopic dermatitis	Clinical diagnosis; routine allergy testing not recommended	Suspected food allergy exacerbating eczema; failure to respond to appropriate treatment
Molluscum contagiosum	Clinical diagnosis; self-limited	Very extensive involvement (consider immunodeficiency); atypical appearance
Erythema infectiosum (fifth disease) in healthy child	Clinical diagnosis; child no longer infectious when rash appears	Child with sickle cell disease or other hemoglobinopathy (check hemoglobin for aplastic crisis)
Roseola infantum	Classic presentation (fever then rash) is diagnostic; self-limited	Atypical presentation; febrile seizures; immunocompromised host
Pityriasis rosea	Clinical diagnosis based on herald patch and distribution; self-limited	Sexually active adolescent (consider secondary syphilis — serology indicated)

Investigation Decision Algorithm

Step-by-Step Approach to Investigating Pediatric Rash:

Is the child ill-appearing or are there red flag features?
- YES → Immediate investigation: full blood count, blood cultures, inflammatory markers, consider lumbar puncture. Treat empirically while awaiting results.
- NO → Proceed to step 2
Is the rash petechial or purpuric?
- YES → Full blood count and coagulation studies mandatory. If febrile or unwell, treat as potential meningococcemia.
- NO → Proceed to step 3
Can a confident clinical diagnosis be made?
- YES → Investigation often not needed (most viral exanthems, urticaria, impetigo, atopic dermatitis)
- NO → Proceed to step 4
Select targeted investigations based on clinical suspicion
- Use the tables above to guide specific testing
- Consider dermatology referral if diagnosis remains unclear

Investigation Pearl: The Value of Serial Examination

In pediatrics, serial examination is often more valuable than immediate investigation. Many rashes evolve over hours to days, and the pattern of evolution can be diagnostic:

Urticaria: Individual lesions should resolve within 24 hours — if they persist longer, consider urticarial vasculitis
Varicella: Lesions should be in multiple stages (macules, papules, vesicles, crusts) — if all lesions are the same stage, reconsider the diagnosis
Henoch-Schönlein purpura: The rash may evolve from urticarial to clearly purpuric over 24-48 hours
Pityriasis rosea: The herald patch appears 1-2 weeks before the generalized eruption

If a child is well-appearing and the diagnosis is uncertain, arranging review in 24-48 hours may be more informative than immediate testing.

7. Pattern Recognition and Clinical Decision-Making

Practical algorithms and decision pathways for pediatric rash

Clinical decision-making in pediatric rash requires rapid assessment of severity, systematic evaluation, and appropriate triage. The primary goal is to identify children who require immediate intervention while appropriately reassuring families of children with benign, self-limiting conditions. This section provides practical algorithms to guide your approach.

Step 1: Is This Urgent?

Clinical Scenario	Urgency Level	Immediate Action
Petechial or purpuric rash + fever + ill-appearing child	EMERGENT	Immediate IV access; blood cultures; empiric ceftriaxone or cefotaxime; fluid resuscitation; notify intensive care
Vesicular rash in neonate (less than 28 days)	EMERGENT	Immediate IV acyclovir; herpes simplex virus polymerase chain reaction (lesion, blood, cerebrospinal fluid); ophthalmology consult
Widespread skin sloughing or blistering + mucosal involvement	EMERGENT	Stop all potential offending drugs; urgent dermatology; consider burn unit transfer; ophthalmology consult; supportive care
Urticaria + respiratory distress or hypotension	EMERGENT	Intramuscular epinephrine; airway management; IV fluids; antihistamines and corticosteroids; monitor for biphasic reaction
Diffuse erythema + skin tenderness + Nikolsky positive (infant)	EMERGENT	Anti-staphylococcal antibiotics (flucloxacillin or clindamycin); fluid management; wound care; monitor for sepsis
Fever ≥5 days + rash + features of Kawasaki disease	URGENT	Admit for evaluation; echocardiogram; intravenous immunoglobulin within 10 days of fever onset to prevent coronary artery aneurysms
Palpable purpura + abdominal pain (Henoch-Schönlein purpura)	URGENT	Assess for intussusception; urinalysis; monitor renal function; pain management; may need admission for observation
Rapidly spreading erythema with fever and pain	URGENT	IV antibiotics for cellulitis; mark borders to track progression; surgical consult if necrotizing fasciitis suspected
Petechial rash + well-appearing + afebrile child	URGENT	Full blood count to exclude thrombocytopenia; if platelets normal and mechanical cause likely, can reassure
Well-appearing child with maculopapular rash	ROUTINE	Clinical assessment; supportive care; parental reassurance; safety-net advice for deterioration
Chronic eczematous rash	ROUTINE	Assessment and treatment plan; education on emollients and trigger avoidance; follow-up as needed
Localized impetigo in well child	ROUTINE	Topical mupirocin for limited disease; oral antibiotics if extensive; hygiene advice; exclude from school until treated

Step 2: Key Assessment Questions

Question 1: Blanching?

Blanching rash:

Blood is within vessels
Suggests vasodilation
Usually less urgent

Non-blanching rash:

Blood is outside vessels
Petechiae or purpura
Requires urgent evaluation

Question 2: Fever?

Febrile with rash:

Infectious etiology likely
Consider serious bacterial infection
Kawasaki if fever ≥5 days

Afebrile with rash:

Allergic, inflammatory, or post-infectious
Generally less urgent
Focus on symptom relief

Question 3: Well or Ill?

Well-appearing:

Playing normally
Eating and drinking
Low risk for serious infection

Ill-appearing:

Lethargic, irritable
Poor feeding
Requires urgent evaluation

Step 3: Decision Pathways by Presentation

Pathway A: Febrile Child with Rash

Clinical Scenario	Most Likely Diagnosis	Action
Fever + petechiae or purpura + ill-appearing	Meningococcemia until proven otherwise	Immediate IV antibiotics; resuscitation; intensive care
Fever ≥5 days + conjunctival injection + lip changes + rash	Kawasaki disease	Admit; echocardiogram; intravenous immunoglobulin
Fever + sandpaper rash + sore throat + strawberry tongue	Scarlet fever	Rapid streptococcal test; penicillin or amoxicillin for 10 days
High fever 3-5 days then rash as fever resolves (infant)	Roseola infantum	Reassurance; supportive care; no specific treatment needed
Fever + vesicles in crops + pruritus	Varicella	Supportive care; consider acyclovir if immunocompromised or severe
Fever + oral ulcers + vesicles on palms and soles	Hand-foot-mouth disease	Supportive care; ensure hydration; pain relief for oral lesions
Fever + maculopapular rash + well-appearing child	Nonspecific viral exanthem	Supportive care; safety-net advice; no investigation needed

Pathway B: Afebrile Child with Rash

Clinical Scenario	Most Likely Diagnosis	Action
Transient wheals + pruritus + lesions lasting less than 24 hours	Acute urticaria	Antihistamines; identify and avoid triggers if known; reassurance
Slapped cheek appearance + lacy rash on extremities	Erythema infectiosum (fifth disease)	Reassurance; child no longer infectious; warn pregnant contacts
Palpable purpura on lower extremities and buttocks + joint pain	Henoch-Schönlein purpura	Urinalysis; monitor for abdominal pain; supportive care; follow-up for nephritis
Honey-crusted lesions around nose and mouth	Impetigo	Topical mupirocin (limited) or oral antibiotics (extensive); hygiene advice
Annular scaly plaque with central clearing	Tinea corporis	Potassium hydroxide preparation to confirm; topical antifungal for 2-4 weeks
Chronic pruritic rash in flexural areas + family history of atopy	Atopic dermatitis	Emollients; topical corticosteroids; trigger avoidance; education
Herald patch followed by oval lesions in Christmas tree pattern	Pityriasis rosea	Reassurance (self-limited 6-8 weeks); symptomatic treatment for itch
Intense nocturnal pruritus + family members also itching	Scabies	Permethrin 5% cream; treat all household contacts simultaneously

Pathway C: Neonatal Rash (0-28 days)

Clinical Scenario	Most Likely Diagnosis	Action
Vesicular rash (any distribution)	Neonatal herpes simplex virus (must exclude)	Immediate IV acyclovir; herpes simplex virus polymerase chain reaction; do not wait for results
Erythematous papules and pustules on trunk (healthy neonate)	Erythema toxicum neonatorum	Reassurance; self-limited; no treatment needed
Yellow greasy scale on scalp	Seborrheic dermatitis (cradle cap)	Emollients; gentle brushing; usually resolves by 6-12 months
Small white papules on face (no inflammation)	Milia	Reassurance; resolves spontaneously; no treatment needed
Papules and pustules on face at 2-4 weeks of age	Neonatal acne	Reassurance; resolves by 3-4 months; no treatment usually needed
Pustules that rupture leaving hyperpigmented macules	Transient neonatal pustular melanosis	Reassurance; benign; self-limited; more common in darker-skinned infants
Ill-appearing neonate with any rash	Neonatal sepsis (consider)	Full sepsis workup; empiric antibiotics; admit to neonatal unit

“What Do I Do If…” Decision Reference

Clinical Situation	Immediate Action	Next Step
The rash is spreading while I’m examining the child	Photograph and mark borders; reassess vital signs frequently	If petechial/purpuric and spreading: immediate antibiotics and resuscitation. If urticarial: monitor for anaphylaxis
The parents show me a photo of a rash that has now resolved	Review photo carefully; note morphology, distribution, timing	If transient wheals: likely urticaria — reassure. If petechial: needs full blood count even if resolved
Child is on antibiotics and develops a rash	Assess for features of severe drug reaction (mucosal involvement, skin pain, blistering)	If severe features: stop drug immediately, urgent referral. If simple morbilliform and child well: can often continue antibiotic with close monitoring
The rash looks like Kawasaki but fever is only 4 days	Document all features; obtain baseline investigations	Arrange review the following day; if fever reaches day 5 with features, treat as Kawasaki disease; consider incomplete Kawasaki
Parent is anxious about “meningitis rash” but child is well with blanching rash	Demonstrate blanching test to parents; thorough examination	Reassure with explanation; provide clear safety-net advice about non-blanching rash and when to return
Petechiae only above the nipple line after vomiting or coughing	Assess for systemic symptoms; check full blood count	If well, afebrile, platelet count normal: mechanical petechiae — reassure. If any concern: observe and repeat full blood count
Child has eczema and develops clusters of vesicles	Consider eczema herpeticum; assess severity and spread	If eczema herpeticum: oral or IV acyclovir depending on severity; urgent ophthalmology if periocular involvement
Rash developed after vaccination	Assess timing and morphology; examine for systemic features	Local reaction: reassure. Mild morbilliform 7-10 days post-MMR: expected, not a contraindication to future doses. Severe reaction: document and refer to immunologist
Diagnosis is uncertain after thorough assessment	Document findings in detail; photograph the rash with consent	If child well: arrange review in 24-48 hours to assess evolution. If unwell: admit for observation and investigation

When to Refer

Urgent Referral (Same Day)

Emergency department or pediatric assessment unit:
- Non-blanching rash with fever or illness
- Suspected Kawasaki disease
- Vesicular rash in neonate
- Stevens-Johnson syndrome or toxic epidermal necrolysis
- Staphylococcal scalded skin syndrome
- Anaphylaxis or severe allergic reaction
Ophthalmology:
- Periocular herpes simplex or zoster
- Stevens-Johnson syndrome (mucosal involvement)
- Kawasaki disease (conjunctival involvement)

Routine Referral (Days to Weeks)

Pediatric dermatology:
- Uncertain diagnosis after initial workup
- Severe or refractory atopic dermatitis
- Suspected genodermatosis
- Extensive psoriasis
- Vascular malformations
- Biopsy required
Pediatric rheumatology:
- Suspected connective tissue disease
- Recurrent Henoch-Schönlein purpura
- Vasculitis with systemic features
Allergy and immunology:
- Recurrent urticaria with identified triggers
- Suspected immunodeficiency
- Severe drug allergy requiring testing

Troubleshooting: When the Rash Does Not Improve

Ask These Questions

Is the diagnosis correct? — Reconsider the differential; some conditions mimic others (scabies can look like eczema; tinea can look like nummular eczema)
Is treatment being used correctly? — Check application technique, frequency, and quantity of topical treatments; assess inhaler technique if relevant
Are triggers being avoided? — Review potential triggers (irritants, allergens, foods, medications, environmental factors)
Is there secondary infection? — Impetiginized eczema requires antibiotics in addition to anti-inflammatory treatment
Is there an underlying condition? — Consider immunodeficiency, nutritional deficiency, or systemic disease in refractory cases
Is adherence an issue? — Explore barriers to treatment adherence (cost, understanding, parental concern about treatments)
Is referral needed? — If initial management fails, timely referral to dermatology is appropriate

8. Clinical Pearls and Pitfalls

Practical wisdom — learn from successes and avoid common mistakes

Must-Know Clinical Pearls

The blanching test is your best friend: Perform it on every child with a rash. Non-blanching rashes (petechiae, purpura) require urgent evaluation regardless of how well the child appears. Use a glass slide or clear plastic cup for the best visualization.

The well-appearing child is your ally: A truly well-appearing child with a blanching rash is unlikely to have a life-threatening condition. Trust your clinical assessment but always provide clear safety-net advice.

Kawasaki disease has a treatment window: Intravenous immunoglobulin is most effective when given within 10 days of fever onset. Do not wait for all criteria to be met — incomplete Kawasaki disease is common and equally dangerous.

Roseola reveals itself as fever resolves: The classic pattern of high fever for 3-5 days followed by rash appearance as the child defervesces is virtually diagnostic. No investigation is needed in a well-appearing infant with this pattern.

Mechanical petechiae have a characteristic distribution: Petechiae from coughing, vomiting, or straining are typically confined to the area above the nipple line (head, neck, upper chest). Petechiae below this line or with systemic symptoms require urgent investigation.

Ask to see the parents’ photos: Parents often photograph their child’s rash at home. These photos can capture transient lesions (urticaria), demonstrate evolution over time, and show the original distribution before treatment or scratching.

Scabies is a family diagnosis: If one family member has scabies, treat the entire household simultaneously. Failure to do so results in reinfection and treatment failure.

The “herald patch” gives pityriasis rosea away: A single larger oval scaly patch appearing 1-2 weeks before the generalized eruption is the key to diagnosing pityriasis rosea. Ask about it specifically in the history.

Henoch-Schönlein purpura has normal platelets: This distinguishes it from idiopathic thrombocytopenic purpura. The purpura in Henoch-Schönlein purpura is palpable (raised) because it is due to vasculitis, not thrombocytopenia.

Amoxicillin plus Epstein-Barr virus equals rash: Nearly 100% of patients with infectious mononucleosis who receive amoxicillin or ampicillin will develop a morbilliform rash. This is not a true penicillin allergy and should not be labeled as such.

Critical Pitfalls to Avoid

Assuming petechiae in a febrile child are benign: Febrile children with petechiae or purpura require immediate evaluation for meningococcemia. Do not be reassured by a well appearance — children can deteriorate rapidly. Give antibiotics first, investigate second.

Missing vesicular rash in neonates: Any vesicular rash in a neonate (less than 28 days) must be treated as potential herpes simplex virus infection until proven otherwise. Start acyclovir immediately — do not wait for test results. Delay can be fatal.

Waiting for all Kawasaki criteria before treatment: Incomplete Kawasaki disease (fever plus fewer than 4 classic criteria) is common, especially in infants. Delay in treatment increases the risk of coronary artery aneurysms. When in doubt, discuss with a pediatric cardiologist or infectious disease specialist.

Dismissing skin pain in drug eruptions: Skin pain or tenderness out of proportion to visible findings is a red flag for Stevens-Johnson syndrome or toxic epidermal necrolysis. Stop the suspected drug immediately and seek urgent specialist input.

Treating tinea capitis with topical antifungals alone: Tinea capitis requires oral antifungal therapy (griseofulvin or terbinafine) — topical treatment does not penetrate the hair follicle adequately. Confirm the diagnosis with potassium hydroxide preparation or culture before starting prolonged oral treatment.

Labeling all drug rashes as “allergies”: Not all rashes during antibiotic treatment are true allergies. The morbilliform rash with amoxicillin in infectious mononucleosis, viral exanthems coinciding with antibiotic use, and minor non-urticarial rashes should not automatically result in permanent allergy labeling, which can limit future treatment options.

Forgetting to examine all skin surfaces: Hidden areas (scalp, behind ears, between fingers and toes, diaper area, soles of feet) often hold diagnostic clues. Scabies burrows in web spaces, tinea capitis on the scalp, and Henoch-Schönlein purpura on the buttocks may be missed with incomplete examination.

Over-investigating well children with common rashes: Unnecessary blood tests cause distress, increase healthcare costs, and may lead to incidental findings requiring follow-up. A well-appearing child with a typical viral exanthem or acute urticaria rarely needs any investigation.

Neglecting follow-up for Henoch-Schönlein purpura: Renal involvement can develop weeks to months after the initial presentation. All children with Henoch-Schönlein purpura need serial urinalysis monitoring for at least 6 months to detect nephritis early.

Treating only the rash without safety-netting: Always provide clear, specific instructions on what signs would prompt return. Parents should know to return if: the child becomes more unwell, the rash becomes non-blanching, there is difficulty breathing, or new concerning symptoms develop.

Key Takeaways

Safety first: The blanching test, assessment of overall appearance, and recognition of red flag features allow rapid identification of children who need urgent intervention
Most pediatric rashes are benign: Viral exanthems, urticaria, and minor skin infections are common and self-limiting — avoid over-investigation and over-treatment in well children
Petechiae and purpura demand action: Non-blanching rashes in febrile or ill children require immediate empiric treatment for meningococcemia
Kawasaki disease has a treatment window: Think of it early when fever persists for 5 days or more with any rash; incomplete presentations are common and equally serious
Neonatal vesicles are herpes until proven otherwise: Start acyclovir immediately in any neonate with vesicular rash — delay can be fatal
Pattern recognition is powerful: Classic presentations (slapped cheek of erythema infectiosum, sandpaper rash of scarlet fever, herald patch of pityriasis rosea) allow confident clinical diagnosis
Morphology guides differential: Accurate identification of the primary lesion (macule, papule, vesicle, pustule, wheal, petechiae) narrows the differential significantly
Distribution tells a story: Central versus peripheral, flexural versus extensor, and dermatomal patterns all provide diagnostic clues
Age matters: The differential varies significantly by age — neonatal rashes, infant rashes, and adolescent rashes each have distinct considerations
Serial examination beats immediate investigation: In a well child with unclear diagnosis, review in 24-48 hours to assess rash evolution is often more informative than blood tests
Treat the whole family for scabies: Failure to treat all household contacts simultaneously is the most common reason for treatment failure
Safety-netting is essential: Always provide clear, specific advice on what signs should prompt immediate return to medical care

Quick Reference Algorithm

Systematic Approach to Pediatric Rash:

Assess overall appearance: Is this child well, mildly ill, or toxic-appearing? Toxic children need immediate resuscitation
Perform the blanching test: Non-blanching rash + fever = meningococcemia until proven otherwise — treat immediately
Take vital signs: Fever changes the differential; tachycardia out of proportion to fever suggests serious illness
Identify the primary lesion: Macule, papule, vesicle, pustule, wheal, or petechiae/purpura? This guides the differential
Map the distribution: Central versus peripheral, localized versus generalized, flexural versus extensor, dermatomal
Look for associated features: Mucosal involvement, lymphadenopathy, joint swelling, systemic symptoms
Consider the age: Neonatal, infant, toddler, school-age, and adolescent presentations differ
Generate a differential: Use probability-based thinking — common conditions are common
Decide on investigation: Most well children with common presentations need no tests; target investigation to clinical suspicion
Initiate treatment and safety-net: Treat appropriately; provide clear written and verbal advice on when to return

The Essential Questions for Every Pediatric Rash

Questions to Ask Yourself

Does this rash blanch?
Is this child well, mildly ill, or seriously ill?
Is there fever, and if so, for how long?
Is there mucosal involvement?
What is the primary lesion morphology?
Does the distribution pattern suggest a diagnosis?
Are there associated systemic features?
Could this be a drug reaction?
Does this need investigation or referral?
What safety-net advice does this family need?

Questions to Ask the Family

When did the rash first appear?
Where did it start, and how has it spread?
Has there been fever?
Is the rash itchy or painful?
Has your child been unwell in any other way?
Any new medications, foods, or products?
Is anyone else at home or school sick?
Is your child vaccinated?
Has your child had similar rashes before?
Do you have any photos from earlier?